David Barreto shared that a London-based research group is conducting a 12-month trial for a new nutraceutical treatment for pattern hair loss, designed with Dr. Carlos Puig. The trial aims to provide robust data, with results expected in 1-2 years, potentially representing a significant advancement since finasteride’s introduction in 1997.
The conversation discusses hair loss treatments, specifically Brassica oleracea extract, glucosinolates, and sulforaphane, and their potential to promote hair growth. Users also mention minoxidil and finasteride as existing treatments.
A 22-year-old experiencing hair loss, initially attributed to stress, found temporary relief with minoxidil but faced increased shedding after stopping and restarting the treatment. The advice given suggests the hair loss may be due to androgenic alopecia rather than stress, recommending consistent use of minoxidil and considering finasteride, with a suggestion to seek a second opinion from another dermatologist.
Way-316606 is considered a potential hair loss treatment but is avoided due to safety concerns and lack of research. Minoxidil and Finasteride are preferred as established treatments.